Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter

from Journal of Clinical Oncology (JCO) Podcast · host Matthew D. Galsky

This podcast reviews the International Bladder Cancer Group’s recommendations regarding definitions and endpoints for the development of non-muscle-invasive bladder cancer clinical trials.

Episode metadata supplied by the publisher feed · Published Jan 25, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter

0:00 9:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 9 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on January 25, 2016.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!